squiffy2 wrote:Panel of multiple sclerosis experts provides best practice treatment recommendations for Tysabri.
Best-practice recommendations for the selection and management of patients with multiple sclerosis (MS) who may benefit from, or are receiving treatment with Tysabri® (natalizumab) were published today in a supplement to th...e medical journal Multiple Sclerosis. More..... http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1905
squiffy2 wrote:Interesting quote from Elan...
“We believe that we’ll have a commercially available assay to detect JC Virus in Q1 2010. We also believe that 50% of MS patients do not have JCV. PML is JCV in the CSF. No JCV means there is very low possibility of PML. It’s a very promising development.”
Raises one question...it is generally quoted in medical papers etc. that "The virus (JC) is very common in the general population, infecting 70 to 90 percent of humans”
Users browsing this forum: No registered users